Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Kaoru Matui"'
Autor:
Di, Zheng, Tadahiro, Yamadori, Tomonori, Hirashima, Kiyoaki, Uryu, Kaoru, Matui, Takashi, Nitta, Masashi, Kobayashi, Shinji, Sasada, Noriyuki, Takimoto, Mitsugu, Furukawa, Yuichirou, Ooba, Caicun, Zhou
Publikováno v:
Zhongguo fei ai za zhi = Chinese journal of lung cancer. 7(4)
To summarize the effect of Iressa for refractory patients with advanced non small cell lung cancer (NSCLC) failed to prior chemotherapy.Thirty-one patients, with unresectable stage IIIB or IV NSCLC who had disease progression or relapse after prior c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5fcea6e2f13915b4f5bead682c62c349
https://pubmed.ncbi.nlm.nih.gov/21241549
https://pubmed.ncbi.nlm.nih.gov/21241549
Autor:
Kiyoyuki Furuse, Yamamoto M, Yoko Kusunoki, Nobuhide Takifuji, Kaoru Matui, Masaaki Kawahara, Kodama N, Shun‐iti Negoro, Masahiro Fukuoka, Minoru Takada, Kaoru Kubota
Publikováno v:
Cancer. 68:714-719
Between August 1983 and March 1985, a randomized study was conducted that compared cisplatin (CDDP) (80 mg/m2 on day 1) alone with CDDP plus vindesine (VDS) (3 mg/m2 on days 1, 8, and 15) in 160 consecutive patients with inoperable non-small cell lun
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::46d41d36c12e3028b4d34696bf09a7fc
https://doi.org/10.1002/1097-0142(19910815)68:4<714::aid-cncr2820680408>3.0.co
https://doi.org/10.1002/1097-0142(19910815)68:4<714::aid-cncr2820680408>3.0.co
Measurement of cytokeratin 19 fragments as a new lung cancer marker by CYFRA 21-1 enzyme immunoassay
Autor:
Minoru Takada, Noriyuki Masuda, Kenji Tamura, Kazuhiko Nakagawa, Takashi Yana, Kaoru Matui, Masahiro Fukuoka, Y. Kusunoki
Publikováno v:
Lung Cancer. 11:36
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::641f33c50c149cfa301cd3546f3dddb8
https://doi.org/10.1016/0169-5002(94)93909-8
https://doi.org/10.1016/0169-5002(94)93909-8